ArticleHemaSphere2025

Event-free survival in early polycythemia vera patients correlates with molecular response to ropeginterferon alfa-2b or hydroxyurea/best available therapy (PROUD-PV/CONTINUATION-PV).

Jean-Jacques Kiladjian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.